March 26, 2026 Sweden
BioStock: Smart money is talking about a Nordic biotech spring
In an article, BioStock highlights Diamyd Medical as a company attracting investor interest ahead of its upcoming Phase III data readout.
Read the article here
Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.